Qube Research & Technologies Ltd - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$22,663
-94.6%
58,260
-93.8%
0.00%
-100.0%
Q2 2023$421,581
+30.4%
944,190
+139.5%
0.00%
+100.0%
Q1 2023$323,301
+94.8%
394,270
+310.1%
0.00%0.0%
Q3 2022$166,000
-53.6%
96,137
-53.5%
0.00%
-66.7%
Q2 2022$358,000
+302.2%
206,767
+735.8%
0.00%
+200.0%
Q1 2022$89,000
-79.5%
24,738
-71.6%
0.00%
-66.7%
Q4 2021$434,000
+1176.5%
86,996
+753.1%
0.00%
+200.0%
Q4 2019$34,00010,1980.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders